Insider Profile
Mandel, Arkady
$TLT
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Aug 24, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Aug 24, 2026 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 14,000 $0.32 $4K 41
Aug 24, 2026 $TLT
Theralase Technologies Inc.
— Open Market Sell 14,000 — — 41
May 20, 2026 $TLT
Theralase Technologies Inc.
— Open Market Sell 11,000 $0.24 $3K 41
May 20, 2026 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 11,000 $0.32 $4K 41
Apr 10, 2026 $TLT
Theralase Technologies Inc.
— Open Market Sell 94,000 $0.26 $24K 41
Apr 10, 2026 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 94,000 $0.36 $34K 41
Jun 17, 2025 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 50,000 $0.30 $15K 41
Jun 17, 2025 $TLT
Theralase Technologies Inc.
— Open Market Sell 50,000 $0.20 $10K 41
Mar 11, 2025 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 40,000 $0.45 $18K 41
Mar 11, 2025 $TLT
Theralase Technologies Inc.
— Open Market Sell 40,000 $0.30 $12K 41
Sep 24, 2024 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 1,500,000 $0.25 $375K 41
Sep 16, 2024 $TLT
Theralase Technologies Inc.
— Expiry Sell 1,500,000 $0.25 $375K 41
Feb 05, 2024 $TLT
Theralase Technologies Inc.
— Open Market Sell 138,889 $0.18 $25K 41
Feb 05, 2024 $TLT
Theralase Technologies Inc.
— Comp. Grant Buy 138,889 $0.25 $35K 41
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.